Pharmaceutical company behind Ozempic invests in Flemish spin-off working on obesity drug
Danish pharmaceutical company Novo Nordisk, together with Dutch investor BioGeneration Ventures, is pumping fresh capital into Tanai Terapeuthics, a young spin-off from the Flanders Institute for Biotechnology (VIB) that is…